688139 海爾生物
按盤價 
31.530 +0.450 (+1.448%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.246 | 9.843 | 15.720 | 26.413 | 14.570 |
| 總資產報酬率 ROA (%) | 5.537 | 7.373 | 11.566 | 19.113 | 10.912 |
| 投入資產回報率 ROIC (%) | 6.713 | 8.891 | 13.683 | 22.569 | 13.141 | 邊際利潤分析 |
| 銷售毛利率 (%) | 48.512 | 50.634 | 48.154 | 50.145 | 50.492 |
| 營業利潤率 (%) | 19.125 | 19.221 | 23.592 | 45.226 | 30.495 |
| 息稅前利潤/營業總收入 (%) | 17.313 | 18.017 | 22.872 | 44.640 | 29.234 |
| 淨利潤/營業總收入 (%) | 17.900 | 18.066 | 21.367 | 39.945 | 27.398 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 91.550 | 72.259 | 84.498 | 45.536 | 75.378 |
| 價值變動淨收益/利潤總額(%) | 4.799 | 19.584 | 10.027 | 50.316 | 22.109 |
| 營業外收支淨額/利潤總額(%) | 0.471 | -0.900 | -0.051 | -0.059 | -0.781 | 償債能力分析 |
| 流動比率 (X) | 2.804 | 2.693 | 2.945 | 3.023 | 2.618 |
| 速動比率 (X) | 2.532 | 2.430 | 2.717 | 2.721 | 2.380 |
| 資產負債率 (%) | 19.502 | 19.649 | 24.424 | 25.737 | 29.374 |
| 帶息債務/全部投入資本 (%) | 3.752 | 4.566 | 8.219 | 11.590 | 11.304 |
| 股東權益/帶息債務 (%) | 2,477.882 | 2,021.390 | 1,074.899 | 738.859 | 753.738 |
| 股東權益/負債合計 (%) | 390.980 | 389.669 | 299.903 | 287.278 | 239.696 |
| 利息保障倍數 (X) | -9.102 | -17.463 | -32.301 | -79.864 | -28.528 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 47.548 | 27.108 | 16.850 | 20.934 | 31.922 |
| 存貨周轉天數 (天) | 74.457 | 82.898 | 74.708 | 100.831 | 91.680 |
| 備註： | 即時報價更新時間為 09/01/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
